Vasopressin infusion in COVID-19 critical illness is not associated with impaired viral clearance: a pilot study

Affiliations

• ¹ Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. Electronic address: dleisman@mgh.harvard.edu.
• ² Department of Medicine, Harvard Medical School, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Massachusetts General Hospital Cancer Center, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
• ³ Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ⁴ Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA.
• ⁵ Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA; Department of Emergency Medicine, Harvard Medical School, Boston, MA, USA.
• ⁶ Department of Medicine, Harvard Medical School, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA; Center for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Department of Microbiology, Harvard Medical School, Boston, MA, USA.